These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 22792392)
1. The transcription factor c-Jun protects against liver damage following activated β-Catenin signaling. Trierweiler C; Blum HE; Hasselblatt P PLoS One; 2012; 7(7):e40638. PubMed ID: 22792392 [TBL] [Abstract][Full Text] [Related]
2. B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver. Reed KR; Athineos D; Meniel VS; Wilkins JA; Ridgway RA; Burke ZD; Muncan V; Clarke AR; Sansom OJ Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18919-23. PubMed ID: 19033191 [TBL] [Abstract][Full Text] [Related]
3. Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Colnot S; Decaens T; Niwa-Kawakita M; Godard C; Hamard G; Kahn A; Giovannini M; Perret C Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17216-21. PubMed ID: 15563600 [TBL] [Abstract][Full Text] [Related]
4. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nateri AS; Spencer-Dene B; Behrens A Nature; 2005 Sep; 437(7056):281-5. PubMed ID: 16007074 [TBL] [Abstract][Full Text] [Related]
5. The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice. Trierweiler C; Hockenjos B; Zatloukal K; Thimme R; Blum HE; Wagner EF; Hasselblatt P Cell Death Differ; 2016 Apr; 23(4):576-82. PubMed ID: 26470729 [TBL] [Abstract][Full Text] [Related]
6. Global increase of p16INK4a in APC-deficient mouse liver drives clonal growth of p16INK4a-negative tumors. Ueberham E; Glöckner P; Göhler C; Straub BK; Teupser D; Schönig K; Braeuning A; Höhn AK; Jerchow B; Birchmeier W; Gaunitz F; Arendt T; Sansom O; Gebhardt R; Ueberham U Mol Cancer Res; 2015 Feb; 13(2):239-49. PubMed ID: 25270420 [TBL] [Abstract][Full Text] [Related]
7. TMEM9-v-ATPase Activates Wnt/β-Catenin Signaling Via APC Lysosomal Degradation for Liver Regeneration and Tumorigenesis. Jung YS; Stratton SA; Lee SH; Kim MJ; Jun S; Zhang J; Zheng B; Cervantes CL; Cha JH; Barton MC; Park JI Hepatology; 2021 Feb; 73(2):776-794. PubMed ID: 32380568 [TBL] [Abstract][Full Text] [Related]
8. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Zhang Y; Wei W; Cheng N; Wang K; Li B; Jiang X; Sun S Hepatology; 2012 Nov; 56(5):1631-40. PubMed ID: 22610915 [TBL] [Abstract][Full Text] [Related]
10. The role of the transcription factor AP-1 in colitis-associated and beta-catenin-dependent intestinal tumorigenesis in mice. Hasselblatt P; Gresh L; Kudo H; Guinea-Viniegra J; Wagner EF Oncogene; 2008 Oct; 27(47):6102-9. PubMed ID: 18679426 [TBL] [Abstract][Full Text] [Related]
11. Wnt-β-catenin signaling protects against hepatic ischemia and reperfusion injury in mice. Lehwald N; Tao GZ; Jang KY; Sorkin M; Knoefel WT; Sylvester KG Gastroenterology; 2011 Aug; 141(2):707-18, 718.e1-5. PubMed ID: 21679710 [TBL] [Abstract][Full Text] [Related]
12. Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo. Buchert M; Athineos D; Abud HE; Burke ZD; Faux MC; Samuel MS; Jarnicki AG; Winbanks CE; Newton IP; Meniel VS; Suzuki H; Stacker SA; Näthke IS; Tosh D; Huelsken J; Clarke AR; Heath JK; Sansom OJ; Ernst M PLoS Genet; 2010 Jan; 6(1):e1000816. PubMed ID: 20084116 [TBL] [Abstract][Full Text] [Related]
13. The concomitant loss of APC and HNF4α in adult hepatocytes does not contribute to hepatocarcinogenesis driven by β-catenin activation. Sartor C; Bachelot L; Godard C; Lager F; Renault G; Gonzalez FJ; Perret C; Gougelet A; Colnot S Liver Int; 2019 Apr; 39(4):727-739. PubMed ID: 30721564 [TBL] [Abstract][Full Text] [Related]
14. Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice. Braeuning A; Gavrilov A; Geissler M; Wenz C; Colnot S; Templin MF; Metzger U; Römer M; Zell A; Schwarz M Arch Toxicol; 2016 Jun; 90(6):1481-94. PubMed ID: 26838046 [TBL] [Abstract][Full Text] [Related]
15. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Apte U; Zeng G; Muller P; Tan X; Micsenyi A; Cieply B; Dai C; Liu Y; Kaestner KH; Monga SP Hepatology; 2006 Oct; 44(4):992-1002. PubMed ID: 17006939 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor signaling regulates the expansion of A6-expressing hepatocytes in association with AKT-dependent β-catenin activation. Utley S; James D; Mavila N; Nguyen MV; Vendryes C; Salisbury SM; Phan J; Wang KS J Hepatol; 2014 May; 60(5):1002-9. PubMed ID: 24365171 [TBL] [Abstract][Full Text] [Related]
17. A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression. Zeineldin M; Cunningham J; McGuinness W; Alltizer P; Cowley B; Blanchat B; Xu W; Pinson D; Neufeld KL Oncogene; 2012 May; 31(19):2423-37. PubMed ID: 21996741 [TBL] [Abstract][Full Text] [Related]
19. Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction. Gan XQ; Wang JY; Xi Y; Wu ZL; Li YP; Li L J Cell Biol; 2008 Mar; 180(6):1087-100. PubMed ID: 18347071 [TBL] [Abstract][Full Text] [Related]
20. The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression. Schulien I; Hockenjos B; Schmitt-Graeff A; Perdekamp MG; Follo M; Thimme R; Hasselblatt P Cell Death Differ; 2019 Sep; 26(9):1688-1699. PubMed ID: 30778201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]